Ketamine Therapy Cost: Pricing by Type, Insurance Coverage, and What to Expect
- IV ketamine infusions typically cost $400-$800 per session; a standard 6-session initial series runs $2,400-$4,800 before any add-on costs.
- Spravato (esketamine nasal spray) is FDA-approved for treatment-resistant depression and can be covered by insurance, though patient cost-sharing still runs $600-$900+ per session initially.
- At-home ketamine via telehealth (sublingual troches) costs $200-$400/month and requires less medical oversight, but is not equivalent to IV protocols in evidence base or monitoring level.
- For treatment-resistant depression, the Number Needed to Treat (NNT) for ketamine is approximately 5-7, which compares favorably to SSRI NNT of 7-9 for partial response.
- Price varies significantly by geography, clinic type, and what is included in the quoted fee; always clarify what the number covers before committing.
Ketamine therapy has gone from a niche psychiatric intervention to a widely available treatment in a short period of time. With that expansion has come significant pricing variation and marketing that does not always make clear what you are actually paying for. A clinic charging $600/session and one charging $1,200/session may be offering very different levels of care, or they may be offering nearly the same thing at different price points based on location and overhead.
This article covers cost by delivery method, what typical protocols look like, what your money should include, and how to evaluate whether the pricing at a specific clinic reflects genuine value. For a complete overview of how ketamine works and which conditions have the strongest evidence, see our Ketamine Therapy Guide.
Cost by Delivery Method
| Delivery Method | Cost Per Session | Typical Protocol | Insurance Coverage | Setting |
|---|---|---|---|---|
| IV infusion (sub-anesthetic) | $400-$800 | 6 sessions over 2-3 weeks; boosters as needed | Not covered (off-label) | Clinic; requires IV access and monitoring |
| IM injection | $200-$500 | Same as IV; slightly fewer sessions sometimes | Not covered | Clinic |
| Sublingual troche (home) | $50-$150 per dose; $200-$400/month subscription | Daily or several times per week | Not covered | Home via telehealth Rx |
| Nasal spray (Spravato/esketamine) | $600-$900 patient cost-share; drug ~$900/dose without coverage | Twice weekly x 4 weeks, then weekly x 4, then biweekly | Covered for TRD and MDD with suicidality (FDA-approved) | Certified healthcare setting (REMS program) |
| Oral (compounded) | $30-$80 per dose | Variable | Not covered | Home |
IV Infusion: The Standard and Its Costs
IV ketamine remains the most studied delivery method and the one most clinics use as the benchmark protocol for treatment-resistant depression (TRD), bipolar depression, PTSD, and chronic pain. The sub-anesthetic dose is typically 0.5 mg/kg infused over 40 minutes, though protocols vary by clinic and indication.
The standard initial series is 6 infusions over 2-3 weeks. Total cost: $2,400-$4,800 for the series alone. After the initial series, most patients require booster infusions at intervals ranging from monthly to quarterly to maintain response. Annual maintenance costs for a good responder doing quarterly boosters: $1,600-$3,200/year on top of the initial series.
What the fee should include: the ketamine medication itself (inexpensive as a generic), IV line placement, monitoring during the infusion (continuous pulse oximetry, blood pressure checks, a nurse or provider present), and time in a recovery area for 30-60 minutes post-infusion. Many clinics also include pre-infusion psychiatric assessment in the initial consultation fee ($150-$300) and provide integration support resources, though dedicated integration therapy sessions typically cost extra.
Spravato (Esketamine): The Insurance Path
Spravato is the S-enantiomer of ketamine administered as a nasal spray. It received FDA approval in 2019 for treatment-resistant depression (defined as failure of two adequate antidepressant trials) and in 2020 for major depressive disorder with acute suicidal ideation or behavior.
Because it is FDA-approved, Spravato is the only ketamine-related treatment that insurance companies are required to cover (subject to formulary and prior authorization requirements). Coverage through commercial insurance and Medicare Part D is available for approved indications, making this the most accessible ketamine option for insured patients with TRD.
The catch: Spravato is administered under the REMS (Risk Evaluation and Mitigation Strategy) program, which requires that patients receive it in a certified healthcare setting and be monitored for at least 2 hours after each dose. It cannot be taken home and self-administered. Patient cost-sharing after insurance typically runs $10-$100/session for patients with commercial insurance and no deductible issues, but out-of-pocket can be $600-$900+ for patients with high deductibles or in the coverage gap period.
At-Home Ketamine Telehealth
Companies like Mindbloom, Joyous, and others offer telehealth-based ketamine prescriptions for sublingual troches (lozenges) that patients take at home. A prescribing provider conducts a virtual assessment, sends troches via a compounding pharmacy, and provides digital support materials. Costs typically run $200-$400/month in subscription form.
The honest trade-offs: sublingual bioavailability for ketamine is about 20-30%, compared to 100% for IV. The dose reaching your bloodstream at therapeutic timing is less predictable. There is no medical monitoring during the session. Most telehealth platforms do not provide integration therapy; they provide app-based guided sessions that substitute for it.
For patients with mild-to-moderate depression who have not tried ketamine before and want a lower-cost entry point, telehealth troches are a reasonable starting option. For treatment-resistant cases or significant psychiatric history, IV at a clinic with psychiatric oversight is the more appropriate choice.
Geographic Price Variation
Ketamine clinic pricing correlates strongly with real estate and local healthcare market costs. In major metropolitan areas (New York, Los Angeles, San Francisco, Chicago), expect to pay $600-$800 per IV infusion. In mid-sized cities and suburban markets, $400-$600 is more typical. In rural areas or lower cost-of-living markets, $350-$500 is possible.
This variation reflects overhead, not efficacy. The ketamine itself costs roughly $5-$20 per dose as a generic. What you are paying for is the facility, monitoring staff, provider time, and the clinical infrastructure. A higher-priced clinic is not necessarily delivering a better ketamine experience, but it may be providing better psychiatric integration, more robust monitoring, or more experienced practitioners.
Does Ketamine Work? The NNT Data
For treatment-resistant depression specifically, ketamine has some of the most compelling short-term response data in psychiatry. Response rates (50%+ reduction in depression scores) within 24 hours of the first infusion run 50-70% across major studies. This rapid onset is unique; SSRIs take 4-8 weeks to show effect.
The Number Needed to Treat (NNT) for ketamine in TRD is approximately 5-7 for short-term response, meaning 1 in 5-7 patients who would not have responded to another treatment will respond to ketamine. For comparison, the NNT for SSRIs in non-resistant depression is 7-9 for a partial response. Ketamine’s NNT advantage narrows or disappears for maintenance at 6-12 months, where the durability data is weaker.
Murrough et al., 2013 (American Journal of Psychiatry, N=47 RCT) compared IV ketamine to midazolam as an active placebo in TRD. Response rate at 24 hours: 64% for ketamine vs. 28% for midazolam. This remains one of the landmark controlled trials in the field.
Comparison to Other TRD Treatments
| Treatment | Initial Cost | Annual Maintenance | Response Rate (TRD) | Insurance Coverage |
|---|---|---|---|---|
| IV Ketamine (6-session series) | $2,400-$4,800 | $800-$3,200 (boosters) | 50-70% at 24 hours; lower at 12 months | No |
| Spravato (esketamine) | Varies by insurance | Biweekly ongoing | ~30-40% remission in trials | Yes (FDA-approved TRD) |
| TMS (Transcranial Magnetic Stimulation) | $6,000-$12,000 (36 sessions) | Varies | 50-60% response; 30% remission | Often covered for TRD |
| ECT (Electroconvulsive Therapy) | $2,500-$5,000 initial series | Ongoing maintenance | 60-80% response | Usually covered |
| SSRI trial (new agent) | $20-$100/month | $240-$1,200/year | 15-25% for additional SSRI in TRD | Yes |
Red Flags in Ketamine Clinic Pricing
Pricing red flags that suggest a clinic is cutting corners: no psychiatric evaluation before starting (ketamine is contraindicated in active psychosis and uncontrolled hypertension); no monitoring during infusions; sessions shorter than 35-40 minutes (sub-therapeutic for depression); pressure to pre-purchase large session packages without a trial; no protocol for what happens if you have a difficult dissociative experience.
Pricing red flags in the other direction: clinics charging $1,500+ per IV infusion without being able to articulate what is included beyond the standard monitoring. Integration therapy bundled at high prices without clarity on credentials of the integration provider. Wellness add-ons (IV vitamins, NAD+ co-infusions) priced on top of an already premium session fee without evidence they improve ketamine outcomes.
What Should Be Included in the Cost
A well-priced ketamine infusion at $500-$700 should include: psychiatric or medical intake evaluation; pre-infusion vital signs and IV placement; the infusion itself with continuous monitoring by a licensed clinician present; post-infusion recovery time with monitoring until you meet discharge criteria; and a follow-up check-in (in person or by phone) after your first session.
Integration therapy (processing the psychological content of ketamine experiences) is best practice but is often not included in the base fee. It is also not strictly required to get antidepressant benefit from ketamine, which is primarily a neurobiological effect rather than a psychedelic processing effect. Budget an additional $150-$250/session if you choose to work with a therapist specializing in integration.
The Bottom Line
Ketamine therapy is expensive relative to oral medications and comparable in cost to other neuromodulation treatments for TRD. For the right patient (failed 2+ adequate antidepressant trials, significant functional impairment), the speed and magnitude of response data justifies the cost in a way that few other add-on treatments can match. For patients with insurance-eligible TRD, Spravato is the most financially accessible ketamine-class option. For those without insurance coverage and with the means to pay out of pocket, IV infusion at a supervised clinic remains the most evidence-backed delivery method.
Related Reading
- Chronic Pain Guide: Types, Mechanisms, and Regenerative Treatment Options
- Ketamine Therapy: Benefits, Risks, Cost, and What to Expect
- TMS Therapy: How Transcranial Magnetic Stimulation Works and Who It Helps
Frequently Asked Questions
How much does ketamine therapy cost per session?
Cost depends on the delivery method. IV infusions run $400 to $800 per session, IM injections $200 to $500, and Spravato (esketamine nasal spray) carries a patient cost-share of $600 to $900 or more per session. At-home sublingual troches are cheaper at $50 to $150 per dose, or $200 to $400 per month by subscription. Prices also vary by location, from $350 to $500 in rural areas up to $600 to $800 in major metros like NYC, LA, SF, and Chicago.
What does a full course of ketamine treatment cost?
A standard IV series is typically 6 sessions over 2 to 3 weeks, which totals $2,400 to $4,800. After that, quarterly maintenance boosters add roughly $1,600 to $3,200 per year. Integration therapy, if you add it, runs an extra $150 to $250 per session.
Does insurance cover ketamine therapy?
Only Spravato is FDA-approved, and because of that it is the only ketamine-related treatment that insurance companies are required to cover, specifically for treatment-resistant depression and major depressive disorder with acute suicidality. IV infusions and at-home options are not covered by insurance, so you would pay out of pocket for those.
How well does ketamine work for depression?
Across major studies, 50 to 70 percent of patients respond within 24 hours of a first IV infusion. The number needed to treat is roughly 5 to 7 for short-term response, compared with 7 to 9 for SSRIs in non-resistant depression, and one cited trial (Murrough et al., 2013) found a 64 percent response for ketamine versus 28 percent for midazolam at 24 hours. The article cautions that this advantage narrows or disappears for maintenance at 6 to 12 months, where the durability data is weaker.
What conditions is ketamine therapy used for?
The article describes ketamine being used for treatment-resistant depression, bipolar depression, PTSD, and chronic pain. Spravato specifically is used for treatment-resistant depression and major depressive disorder with suicidality.
Is at-home ketamine as effective as IV at a clinic?
At-home sublingual troches have only 20 to 30 percent bioavailability compared with 100 percent for IV, and no medical monitoring happens during at-home sessions. The article notes that for treatment-resistant cases or a significant psychiatric history, IV at a clinic with psychiatric oversight is the more appropriate choice than telehealth.
